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Background: The enhancement of migration is critical for facilitating cancer cell metastasis.
Method: Lung cancer H23 cells were transfected with either a caveolin-1 (Cav-1) overexpression or shCav-1 plasmid
and further subjected to cell migration assays and lamellipodia characterization. The regulation of Cav-1 via an
ATP-dependent tyrosine kinase (Akt) pathway was further examined by Akt knockdown in Cav-1 overexpressing
cells and migratory behavior investigations.
Results: Here, we demonstrate for the first time that overexpression of Cav-1 in human lung cancer H23 cells
significantly increased the formation of lamellipodia, whereas the suppression of Cav-1 using shRNA transfection
had the opposite effect. Consistent with an increase in lamellipodia, Cav-1 overexpressing cells exhibited increased
migratory activity in comparison to their parental, control-transfected, H23 cells. The induction of lamellipodia was
demonstrated to occur via the Akt pathway because the addition of the Akt inhibitor LY294002 inhibited lamellipodia
in both Cav-1-overexpressing and H23 cells. Additionally, transient transfection with Akt-siRNA significantly inhibited
the formation of lamellipodia and the migration of Cav-1-overexpressing H23 cells. In addition, Cav-1 levels and the
migratory action of other lung cancer cells, namely, H460 and A549, were assessed, and the migration of these cells
was found to be correlated with the basal Cav-1 level.
Conclusion: These data showed that Cav-1 enhances cancer cell migration through Akt-mediated lamellipodia
formation. Our results provide novel insights regarding the molecular mechanism controlling cancer cell migration,
leading to a better understanding of cancer cell biology.
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Understanding the molecular mechanisms that control
cancer cell behavior is important for the development of
novel anti-cancer strategies. In lung cancer, an enhanced
migration ability of the cells is among the key factors fa-
cilitating metastasis, a major cause of death in this type
of cancer. Therefore, strategies that inhibit or attenuate
the process of cancer dissemination, including migration,
have garnered much research attention in the field.
Lamellipodia are widely accepted to be critical for dir-
ectional migration in many cells [1]. In cancer, an in-
creased amount of lamellipodia is frequently found in
highly motile cells, and lamellipodia are believed to play
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article, unless otherwise stated.[2]. Indeed, cell migration is initiated by the formation
of pseudopodia such as lamellipodia, sheet-like cellular
protrusions that are enriched with F-actin. The forma-
tion of lamellipodia involves multi-step processes of
actin polymerization and depolymerization [3]; actin fila-
ments are arranged into a sheet-like network of lamelli-
podia at the leading edge of the cells during movement
[3]. The defined molecular pathways controlling the for-
mation of lamellipodia have been elusive to date, and
such insight is considerably vital to the discovery of
novel molecular targets in the development of anti-
metastasis therapies.
Caveolin-1 (Cav-1), a protein comprising the portions of
membranes called caveolae, was previously shown to have
a potentiating effect on the progression of cancers [4-7].
In addition, the expression level of Cav-1 was shown to be
associated with a poor prognosis and metastasis in severalCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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cers [10]. In particular, Cav-1 was reported to be a key
regulator of anoikis resistance [4-6] and migration and in-
vasion [7]; however, its regulatory role in controlling la-
mellipodia and the possible regulatory mechanism are
largely unknown. Therefore, we aimed to investigate the
possible impact of the Cav-1 protein on lamellipodia for-
mation and cancer cell motility in human lung cancer
cells. For the first time, we show that Cav-1 induces the
formation of lamellipodia and increases tumor cell motil-
ity through an Akt-dependent mechanism. Our study sug-
gests the novel hypothesis that the Cav-1 protein has a
positive regulatory function in the process of cancer cell
metastasis.
Results
Caveolin-1 enhances lamellipodia formation and
migration in non-small cell lung cancer H23 cells
To test the effect of Cav-1 protein in the regulation of
lamellipodia formation, we stably transfected H23
cells with Cav-1-overexpression, control, shRNA-Cav-
1 or shCtrl plasmids and selected stable transfectants using
an appropriate protocol. The Cav-1 overexpressing (H23/
Cav-1), H23 control (H23/Ctrl), Cav-1 knockdown (H23/
shCav-1) and shRNA control (H23/shCtrl) cells were ana-
lyzed for Cav-1 levels using western blotting, as described
in Materials and Methods. Figure 1A shows that the cells
transfected with the Cav-1 overexpression plasmid exhib-
ited a higher level of the protein in comparison to that of
the control cells. In contrast, the shCav-1 transfectants had
the lowest level of Cav-1.
Furthermore, these cells were analyzed for the forma-
tion of cell protrusions under inverted light microscopy
and fluorescence microscopy. Figure 1B and C indicate
that the Cav-1-overexpressing cells exhibited a signifi-
cant increase in the number of sheet-like lamellipodia in
comparison to that of the parental H23 cells, whereas
the Cav-1-knockdown cells displayed the fewest number
of lamellipodia. These results demonstrate for the first
time that Cav-1 plays a positive role in the formation of
cellular lamellipodia in lung cancer cells.
Lamellipodia enhances H23 cell migratory activity
Because lamellipodia were linked to the migratory activ-
ity of the cells, we further tested whether such presented
lamellipodia are associated with cell migration. Figure 2
shows that Cav-1-overexpressing H23 cells exhibited the
dominant migratory activity across a wound space; the
shCav-1-transfected cells showed the opposite behavior.
Additionally, the relative migration level obtained from
Transwell assays, as described in Materials and Methods,
indicated a similar trend that the cells possessing a
higher level of Cav-1 migrate faster than the control
group and shRNA-Cav-1-transfected cells. These dataare consistent with previous reports that lamellipodia in
cancers are associated with cell motility. Our results re-
veal the positive role of Cav-1 on lamellipodia formation
and cancer cell migration.
Caveolin-1 enhances lamellipodia via an Akt-dependent
mechanism
Akt was shown to play a critical role in mediating cancer
cell migration through the induction of actin polymerization
[11,12]. To provide the possible underlying mechanism of
the inductive effect of Cav-1 on lamellipodia in these
cells, we tested whether Cav-1 up-regulates lamelli-
podia in an Akt-dependent mechanism. The Cav-1-
overexpressing and control H23 cells were subjected to
a western blot analysis to assess the level of activated
Akt and total Akt. The results indicated that the Cav-1-
overexpressing cells showed an increased level of acti-
vated Akt (phosphorylated Akt at Ser473), whereas the
level of total Akt was comparable to that of the control
H23 cells (Figure 3A).
In addition, we tested whether such up-regulation of
activated Akt plays a role in controlling lamellipodia for-
mation in these cells. Cells overexpressing Cav-1 and
control H23 cells were treated with LY294002, a select-
ive PI3K/Akt inhibitor, for 24 h, and lamellipodia were
examined as described. Figure 3B shows that treatment
with the Akt inhibitor significantly inhibited lamellipodia
formation in these cells, consistent with a suppression of
Akt activation (Figure 3A). These data indicate that Cav-
1 enhances lamellipodia in cells via Akt up-regulation.
To confirm the role of Akt in Cav-1-lamellipodia regu-
lation in these cells, Cav-1-overexpressing cells were
transiently transfected with siRNA-Akt, and lamellipodia
were analyzed. Western blotting revealed that both total
and phosphorylated Akt in the cells transfected with
siRNA-Akt were significantly decreased (Figure 4A). Add-
itionally, the migratory activity of the H23/Cav-1 cells was
significantly suppressed by the transfection with the
siRNA targeting Akt (Figure 4B and C). In accordance
with the above finding, we found that the siRNA transfec-
tants exhibited dramatically low levels of lamellipodia per
cell (Figure 4D). Taken together, these results reveal a
novel molecular pathway in the regulation of cancer cell
migration via Cav-1 and Akt pathways.
The endogenous Caveolin-1 level correlates with human
lung cancer cell migratory behavior
Others and we have reported the potentiating action of
Cav-1 on cancer aggressiveness and metastasis [4-10].
Thus, we assessed whether the basal expression level of
Cav-1 in human lung cancer cells could affect their migra-
tion. Human lung cancer cells, namely, H460, H23 and
A549 cells, were analyzed for endogenous Cav-1 levels by
a western blot analysis. Additionally, the migratory activity
Figure 1 (See legend on next page.)
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Figure 1 Caveolin-1 enhances lamellipodia formation in lung cancer H23 cells. (A) Cells were transfected with Cav-1 overexpressing, control,
shCav-1 or shRNA scrambled plasmids and analyzed for Cav-1 level by western blotting. The blots were reprobed with β-actin to confirm equal
loading. The immunoblot signals were quantified by densitometry, and mean data from independent experiments were normalized to the results.
The bars are the means ± SD (n = 4). *, p < 0.05 vs. control (H23/Ctrl) or shRNA scrambled (H23/shCtrl) transfected cells. (B) Lamellipodia in the
transfected cells was indicated by arrow. Data represent as relative number of lamellipodia/cell as described in Material and Methods. Plots are
mean ± SD (n = 4). *, p < 0.05 vs. control (H23/Ctrl) or shRNA scrambled (H23/shCtrl) transfected cells. Lamellipodia at the edge of cells were indi-
cated by arrow. (C) Transfected cells were stained with phalloidin-rhodamine and visualized under fluorescent microscope.
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Figure 5 shows that A549 cells, which possess the high-
est level of Cav-1 protein among the tested cells, exhib-
ited the highest degree of migration. In contrast, H460
cells, which had the lowest basal Cav-1 level, showed
the least migration. These results support the above
finding that Cav-1 has a positive role in the regulation
of lung cancer cell migration.A
B
Figure 2 Caveolin-1 increases lung cancer H23 cell migration. (A) Con
shRNA-Cav-1-transfected (H23/shCav-1), and shRNA scrambled (H23/shCtrl)
for 24 h. The wound space was visualized under a microscope and represe
vs. control transfected cells. (B) For transwell assay, cell migration was exam
side of the membrane were stained with Hoechst 33342 for 30 min and viDiscussion and Conclusion
The migratory activity of cancer cells is generally recog-
nized as an important factor for successful metastasis.
In lung cancer, the high mortality rate is caused by can-
cer metastasis, which in this type of cancer is frequently
found at the time of diagnosis [13]. Cancer researchers
have paid much attention to identifying possible strat-
egies for inhibiting cancer migration, and knowledge offluent monolayers of Cav-1 transfected (H23/Cav-1), control (H23/Ctrl),
cells were wounded using a 1-mm-wide tip and allowed to migrate
nted as relative migration level. Data are means ± SD (n = 4). *, p < 0.05
ined by a transwell assay for 24 h. Migratory cells at the basolateral
sualized under a fluorescence microscope.
Figure 3 Effect of Akt inhibitor on lamellipodia formation. (A)
Cav-1 overexpressed (H23/Cav-1) and control (H23/Ctrl) H23 cells
were treated with Akt inhibitor (LY294002) at the concentration of
10 μM. Expression level of total Akt and activated Akt was determined.
The blots were reprobed with β-actin to confirm equal loading. (B)
Lamellipodia in control (H23/Ctrl) and Cav-1 overexpressing (H23/
Cav-1) cells were indicated by arrow. Data were plotted as relative
number of lamellipodia per cell in each field and represented the
means ± SD (n = 4). *, p < 0.05 vs. control transfected (H23/Ctrl) cells
at each treatment.
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critical.
Cav-1 is a major protein component of the cell struc-
tures called caveolae. This protein has lately garnered a
significant amount of attention in cancer research be-
cause a large number of studies have indicated its role in
potentiating cancer cells in many ways [14-16]. Recently,
we reported a role for Cav-1 in the regulation of anoikis
[4-6], migration and invasion [7] in a lung cancer cell
model; however, its role in controlling lamellipodia is
still unknown. The migration of cancer cells involves
several regulatory proteins, and among them Akt plays a
central role. An increase in cellular activated Akt is ob-
served in metastatic tumors, and activated Akt has been
shown to increase cell motility [17,18]. Akt contributes
to the polymerization of actin protein, resulting in the
cell protrusions called lamellipodia. Here, we reveal for
the first time that Cav-1 has a function in controlling
the lamellipodia formation that leads to cell migration.
The number of lamellipodia per cell has been correlated
with an increased migratory behavior of cancer cells
[2,19,20]. Our results are consistent, as we found that
both lamellipodia and migration significantly increased
in Cav-1-overexpressing cells (Figures 1 and 2). Add-
itionally, shRNA transfection confirmed this function of
Cav-1 by causing the opposite effect.
To provide a molecular mechanism by which Cav-1
regulates lamellipodia, an Akt inhibitor as well as
siRNA-Akt were used. We found that the decrease in ac-
tivated Akt caused by the Akt inhibitor or siRNA trans-
fection was able to abolish the effect of Cav-1 (Figures 3
and 4), suggesting that Cav-1 up-regulates lamellipodia
via an Akt-dependent mechanism. Because the up-
regulation Cav-1 was demonstrated in tumor tissues
from patients and the high expression level of this pro-
tein was linked to a poor prognosis, we hypothesized
that the basal expression level of Cav-1 protein may
affect the migratory activity of lung cancer cells. Human
lung cancer cells, including H460 and A549 cells, were
subjected to a western blot analysis, and our results
showed that the cells possessing a higher level of Cav-1
exhibited greater motility (Figure 5). These observations
support the results of our experiments that an increase
Figure 4 Caveolin-1 regulates lamellipodia via Akt-dependent mechanism. Cav-1 overexpressed (H23/Cav-1) cells were transfected with
siRNA-Akt. (A) Akt and activated Akt levels were analyzed by western blot analysis. The immunoblot signals were quantified by densitometry, and
mean data from independent experiments were normalized to the results. The bars are the means ± SD (n = 4). *, p < 0.05 vs. control transfected
(H23/Cav-1) cells. (B) Migratory activity of H23/Cav-1 transfected with siRNA-Akt was determined by wound healing assay. Data represent the
means ± SD (n = 4). *, p < 0.05 vs. control transfected (H23/Cav-1) cells. (C) Migratory activity of Cav-1 overexpressing cells transfected with either
siAkt or control plasmid were investigated by transwell migration assay as described. (D) Lamellipodia in the cells were investigated and indicated
by arrow as described.
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ity. Although the migration activity of lung cancer cells is
likely to involve several pathways, our results and observa-
tions indicate that Cav-1, at least in part, plays a critical
role in the regulation of lung cancer cell migration.
In conclusion, the present study reveals information
regarding an endogenous protein that plays a significant
role in cancer cell behavior. This insight may provide abetter understanding of lung cancer and lead to the de-
velopment of novel therapies.
Materials and Methods
Cells and reagents
The non-small cell lung cancer (NSCLC) cell lines H23,
A549 and H460 were obtained from the American Type
Culture Collection (Manassas, VA). The cells were cultured
Figure 5 Basal level of Caveolin-1 in lung cancer cells correlates with their migratory potential. (A) H460, H23, and A549 were analyzed
for endogenous Cav-1 level by western blot analysis. (B) Migration of all cells was determined as described in Materials and Methods. Data
represent the means ± SD (n = 4). *p < 0.05 vs. H23 cells.
Chanvorachote et al. Cancer Cell International 2014, 14:52 Page 7 of 9
http://www.cancerci.com/content/14/1/52
Chanvorachote et al. Cancer Cell International 2014, 14:52 Page 8 of 9
http://www.cancerci.com/content/14/1/52in RPMI-1640 supplemented with 5% fetal bovine
serum (FBS), 2 mM L-glutamine and 100 units/mL
penicillin/streptomycin. The cells were incubated in a
5% CO2 environment at 37°C. Phalloidin tetramethylr-
hodamine B isothiocyanate and LY294002 were ob-
tained from Sigma Chemical, Inc. (St. Louis, MO).
Antibodies against pan-Akt, p473-Akt, FAK, caveolin-1
and β-actin and peroxidase-conjugated secondary anti-
bodies were obtained from Cell Signaling Technology,
Inc. (Danvers, MA).
Migration assay
Migration was determined by wound-healing and Trans-
well assays. For the wound-healing assay, a monolayer of
cells was cultured in a 24-well plate, and a wound was
achieved using a 1-mm-wide pipette tip. The cell mono-
layers were allowed to migrate for 24 h. Micrographs
were taken under a phase-contrast microscope (Olympus
DP70, Melville, NY), and the wound spaces were mea-
sured from 10 random fields of view using Olympus DP
controller software. A quantitative analysis of cell migra-
tion was performed using an average wound space from
those random fields of view, and the percentage of change
in the wound space was calculated using the following for-
mula: % change = (average space at time 0 h) - (average
space at time 24 h)/(average space at time 0 h) × 100. For
the Transwell assay, the cells were seeded in serum-free
medium at a density of 5 × 104 cells/well in the upper
chamber of a Transwell device (8 μm pore size) in a 24-
well plate and incubated for 24 h. RPMI medium con-
taining 10% FBS was added to the lower chamber. Fol-
lowing the incubation, the non-migrated cells in the
upper chamber were removed by wiping with a cotton
swab, and the cells that migrated to the underside of
the membrane were stained with 10 μg/mL Hoechst
33342 for 10 min, visualized and scored under a fluor-
escence microscope (Olympus IX51 with DP70).
Cell morphology and lamellipodia characterization
Cell morphology was investigated by a phalloidin-rhodamine
staining assay. The cells were seeded at a density of
5×103 cells/well in a 96-well plate overnight. The cells
were washed with PBS, fixed with 4% paraformaldehyde
in PBS for 10 min at 37°C, permeabilized with 0.1%
Triton-X100 in PBS for 4 min and blocked with 0.2%
BSA for 30 min. Afterwards, the cells were incubated
with 1:100 phalloidin-rhodamine in PBS for 15 min,
rinsed 3 times with PBS and mounted with 50% gly-
cerol. Cell morphology was assessed by fluorescent im-
aging (Olympus IX51 with DP70). The lamellipodia
were calculated from an average number of flat sheet-
like structures per cell, counting all of the cells present
in the field (at least 50 cells/field), and represented as a
number relative to the control [21,22]. At least 5random fields were captured per sample, and four inde-
pendent experiments were performed.
Plasmids and transfection
The Cav-1 expression plasmid, Cav-1 knockdown shRNA-
Cav-1 plasmid and control empty and shRNA scrambled
vectors were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA). Stable transfections of the Cav-1 ex-
pression plasmid or Cav-1 knockdown plasmid were gen-
erated by culturing H23 cells in a 6-well plate until they
reached 60% confluence. Lipofectamine reagent (15 ml)
and 2 mg of Cav-1 or shRNA-Cav-1 plasmid were used to
transfect the cells in the absence of serum. After 12 h, the
medium was replaced with a culture medium containing
5% fetal bovine serum. Approximately 36 h after the be-
ginning of the transfection, the cells were digested with
0.03% trypsin; the cell suspensions were seeded in 75-ml
culture flasks and cultured for 24 to 28 days with drug se-
lection. The stable transfectants were pooled, and the
expression of Cav-1 protein in the transfectants was con-
firmed by western blotting. The cells were cultured in
antibiotic-free RPMI-1640 medium for at least two pas-
sages before use in each experiment. For transient Akt
knockdown, 15 ml of Lipofectamine reagent and 2 mg of
either siAkt or control plasmid were mixed and applied to
60% confluent cavolin-1-overexpressing (H23/Cav-1) cells.
After 12 h, the medium was replaced with a culture
medium containing 5% fetal bovine serum. The trans-
fected cells were used for experiments at approximately
36 h after the beginning of the transfection.
Western blotting
Cells were incubated in lysis buffer containing 20 mM
Tris–HCl (pH 7.5), 1% Triton X-100, 150 mM sodium
chloride, 10% glycerol, 1 mM sodium orthovanadate, 50
mM sodium fluoride, 100 mM phenylmethylsulfonyl
fluoride and a commercial protease inhibitor cocktail
(Roche Molecular Biochemicals) for 30 min on ice. The
cell lysates were collected, and the protein content was
determined using the Bradford method (Bio-Rad Labora-
tories, Hercules, CA). Equal amounts of protein from
each sample (60 μg) were denatured by heating at 95°C
for 5 min in Laemmli loading buffer and were subse-
quently loaded onto a 10% SDS-polyacrylamide gel.
After separation, the proteins were transferred onto
0.45-μm nitrocellulose membranes (Bio-Rad). The mem-
branes were blocked for 1 h in 5% nonfat dry milk in
TBST (25 mM Tris–HCl (pH 7.5), 125 mM NaCl and
0.05% Tween 20) and incubated overnight with the ap-
propriate primary antibodies at 4°C. The membranes
were washed twice with TBST for 10 min and incubated
with horseradish peroxidase-coupled isotype-specific
secondary antibodies for 1 h at room temperature. The
immune complexes were detected by enhancement with
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Pierce) and quantified using analyst/PC densitometry soft-
ware (Bio-Rad).
Statistical analysis
The mean data from independent experiments were nor-
malized to the results for the cells in the control group. All
of the experiments were repeated at least four times. A stat-
istical analysis between two groups was verified by Student’s
t-test; to compare multiple groups, an analysis of variance
(ANOVA) with a post-hoc test was conducted. A p-value of
less than 0.05 was considered statistically significant.
Abbreviations
Akt: ATP-dependent tyrosine kinase; PBS: phosphate-buffered saline;
p-Akt: phosphorylated-Akt; Cav-1: caveolin-1; TBST: Tris-buffered saline
containing Tween.
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